Shoulder Innovations, Inc.
NYSE:SIMedical - Specialties
-$0.13 today
- Market cap
- $432.04M
- Beta
- -1.07
- P/E (TTM)
- -8.4
- EPS (TTM)
- -$2.13
Volume 0.09M
Average 0.10M
SI Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
Shoulder Innovations, Inc.NYSE: SI
Accumulated OCI · Q1 FY2026 · quarter ended Mar 2026
Accumulated OCI turns negative
Q1 FY2026 Accumulated OCI was -$64K, compared with $81K a year earlier.
Context
- Accumulated OCI amounted to 0.0% of total assets at the end of Q1 FY2026, down 0.1 pp from a year earlier.
- Accumulated OCI increased in 0 of the last 2 fiscal years.
- FY2025 was the lowest annual figure in the 3 fiscal years shown.
What to watch
Whether Accumulated OCI keeps falling in the next quarterly balance sheet after a -179.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- -100.0%
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | -100.0% |
| FY2024 | 2024-12-31 | 197K | -44.7% |
| FY2023 | 2023-12-31 | 356K | — |
Accumulated OCI vs competitors
How SI compares with its peers on the latest reported figures
- SI's Mar 2026 Accumulated OCI of -$64K is the 5th highest of the 11 companies compared; the peer median is -$82K.
- Its year-over-year change of -179.0% is the 9th highest of 11, against a peer median of -27.3%.
- Accumulated OCI amounts to 0.0% of total assets for SI, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $3.42M | +768.3% | — | 1.2% | |
| Mar 2026 | $14K | -68.2% | — | 0.0% | |
| Mar 2026 | $10K | +0.0% | — | 0.0% | |
| Dec 2025 | $0 | +100.0% | — | 0.0% | |
| Mar 2026 | -$64K | -179.0% | — | 0.0% | |
| Mar 2026 | -$73K | -183.0% | — | 0.0% | |
| Mar 2026 | -$91K | -148.1% | — | 0.1% | |
| Mar 2026 | -$368K | -45.5% | — | 0.2% | |
| Jun 2026 | -$654K | +21.1% | — | 0.5% | |
| Mar 2026 | -$734K | -227.7% | — | 0.2% | |
EPRXEupraxia Pharmaceuticals Inc. | Mar 2026 | -$4.5M | -9.1% | — | 3.1% |
| Peer median (excluding SI) | -$82K | -27.3% | — | 0.1% | |
Competitors are the stored peer set for SI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Shoulder Innovations, Inc.
NYSE:SI
Intrinsic Alpha fair value
Locked
Current Price
$20.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.